Metrikler
Yayın
5
Açık Erişim
1
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (2)
SCI-E, SSCI, AHCI (2)
SCI-E, SSCI, AHCI, ESCI (2)
Scopus (2)
TRDizin (1)
2020
20201. The outcomes of fertility sparing surgery in epithelial ovarian cancer
KARABÜK E., Karadag B., KARADAĞ C., KÖSE M. F., Naki M. M., GÜLER E. N.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
, cilt.41, sa.3, ss.391-395, 2020 (SCI-Expanded, Scopus)
2020
20202. Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial
Demir A., Mandel N. M., PAYDAŞ S., Demir G., ER O., Turhal N. S., et al.
BALKAN MEDICAL JOURNAL
, cilt.37, sa.2, ss.104-107, 2020 (SCI-Expanded, Scopus, TRDizin)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2024
20241. Artificial intelligence algorithms for recurrence risk score prediction in early-stage breast cancer: A multicenter study of 437 cases
BAYRAM E., Basaran G., Gokmen E., Mandel N. M., Oyan B., Uskent N., et al.
Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024, (Özet Bildiri)
2015
20152. Results of the Turkish prospective multi-center study utilizing the 21-gene Oncotype DX assay: Decision impact analysis.
Ozmen V., Atasoy A., Gokmen E., Ozdogan M., Guler E. N., Uras C., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2013
20133. Outcomes of patients with HER2-negative breast cancer with central nervous system metastasis treated with capecitabine.
Altundag K., Aksoy S., Sendur M. A. N., Guler E. N., Gullu I. H., Ozisik Y. Y.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)